http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bb8f88a5d564122b57d2b514e5648c3
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Corti |
| name | Angelo Corti |
| given-name | Angelo |
| organization-name | Department of Oncology and IIT Network Research Unit of Molecular NeurosciencesSan Raffaele H Scientific InstituteMilanItaly 3Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; 5Vita-Salute San Raffaele University, Milan, Italy. The Lepetit Research Center, Milan, Italy Tumor Biology and Vascular Targeting Unit, Division of Molecular OncologySan Raffaele Scientific Institute Milan Italy; Italian Institute of Technology Network of Molecular Neuroscience, Division of Molecular OncologySan Raffaele Scientific Institute Milan Italy 2Università Vita-Salute San Raffaele, Milan, Italy.; 5Division of Experimental Oncology, San Raffaele Scientific Institute, Milan, Italy. Division of Molecular Oncology and IIT Network Research Unit of Molecular Neuroscience San Raffaele Scientific Institute via Olgettina 58, 20132 Milan Italy 1Division of Experimental Oncology, San Raffaele Scientific Institute, Milan, Italy.; 4Università Vita-Salute San Raffaele, Milan, Italy. Department of Biological and Technological Research, Cancer Immunotherapy and Gene Therapy Program, San Raffaele H Scientific Institute, Milan, Italy Department of Oncology, San Raffaele Scientific Institute, Milan, Italy IRCCS Ospedale San Raffaele Via Olgettina 60 20132 Milan Italy Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy. corti.angelo@hsr.it. Department of Medicine, Oncology and Clinical Immunology Unit, H San Raffaele Scientific Institute and Università Vita-Salute San Raffaele , Milan , Italy; Department of IIT Network-Molecular Neuroscience Unit , Milan , Italy Department of Oncology, Cancer Immunotherapy and Gene Therapy Program, San Raffaele H Scientific Institute, Milan, Italy Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy 8Immunobiotechnology Unit, San Raffaele Institute, Milan, Italy; and DIBIT-Department of Oncology and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, Milan, Italy; and Merrell Dow Research Institute, Lepetit Research Center, Gerenzano (Varese), Italy Tumor Biology and Vascular Targeting Unit, Division of Molecular Oncology (A.C., M.B.), San Raffaele Scientific Institute, 21032 Milan, Italy Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; San Raffaele Vita-Salute University, Milan 20132, Italy 1Department of Biological and Technological Research and Cancer Immunotherapy and Gene Therapy Program, San Raffaele H. Scientific Institute, Milan, Italy, and Tumor Biology and Vascular Targeting Unit IRCCS San Raffaele Scientific Institute 16132 Milan Italy; Vita Salute San Raffaele University 16132 Milan Italy Tumor Biology and Vascular Targeting Unit San Raffaele Scientific Institute Milan Italy IRCCS San Raffaele Scientific Institute and Vita Salute San Raffaele University Milan 20132 Italy Department of Biological and Technological Research, and Cancer Immunotherapy and Gene Therapy Program, San Raffaele H. Scientific Institute, 20132 Milan, Italy Tumor Biology and Vascular Targeting Unit, Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy; and Tumor Biology and Vascular Targeting Unit; San Raffaele Scientific Institute; Milano Italy Division of Molecular Oncology, San Raffaele Scientific Institute and VIta Salute San Raffaele University, Milan 20132, Italy; †Program of Immunology, Gene Therapy and Bio-Immunotherapy of Cancer, San Raffaele Scientific Institute, 20132 Milan, Italy;; §Tumor Biology and Vascular Targeting Unit, San Raffaele Scientific Institute, 20132 Milan, Italy; 1Department of Biological and Technological Research and Cancer Immunotherapy and Gene Therapy Program, San Raffaele H Scientific Institute, Milan, Italy 1DIBIT-Department of Oncology, Cancer Immunotherapy and Gene Therapy Program, San Raffaele H. Scientific Institute; Division of Experimental Oncology IRCCS San Raffaele Scientific Institute Vita‐Salute San Raffaele Milan 20132 Italy San Raffaele Scientific Institute, Milan, Italy Authors' Affiliation: Division of Molecular Oncology and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, Milan, Italy Division of Molecular Oncology, San Raffaele Scientific Institute, 20132 Milan, Italy; Cancer Immunotherapy and Gene Therapy Program, H San Raffaele Scientific Institute and San Raffaele Vita-Salute University, Milano, Italy Università Vita-Salute San Raffaele, Milan 20132, Italy; Tumor Biology and Vascular Targeting Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy IRCCS San Raffaele Scientific Institute San Raffaele Vita‐Salute University Milan Italy Division of Molecular Oncology and IIT Network of Molecular Neuroscience, San Raffaele Scientific Institute University Hospital, 60 Olgettina St, 20132 Milan, Italy Division of Experimental OncologyVita-Salute San Raffaele UniversityIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific InstituteMilanItaly From the Cattedra di Cardiologia, Università degli Studi di Brescia (R.F., R.C., O.V.); the Centro di Fisiopatologia Cardiovascolare “Salvatore Maugeri,” Fondazione Clinica del Lavoro, Gussago, Brescia (T.B.); the Heart Failure Unit, Fondazione Clinica del Lavoro, Montescano, Pavia (C.O., O.F.); and Tecnogen ScpA, Piana di Monte Verna, Caserta (A.C., G.C.), Italy. Department of Pathology and Molecular Medicine and Tumor Biology and Vascular Targeting Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. 1Department of Biological and Technological Research-Department of Oncology, CIGT Program and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, IRCCS San Raffaele Scientific Institute and Vita Salute San Raffaele University 16132 Milan Italy IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132 Milan, Italy Department of Biological and Technological Research, Cancer Immunotherapy and Gene Therapy Program, San Raffaele H Scientific Institute Authors' Affiliation:Division of Molecular Oncology and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, Milan, Italy DIBIT, San Raffaele H Scientific Institute, Milan,1 and 6IRCCS San Raffaele Scientific InstituteSan Raffaele Vita-Salute University, Milan, Italy Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, San Raffaele Vita-Salute University, Milan, Italy 1Department of Oncology, Cancer Immunotherapy and Gene Therapy Program, San Raffaele Scientific Institute and MolMed SpA, Milan, Italy (PDM,CGS,LA,CT,GPR); Vita-Salute University (PDM); Division of Molecular Oncology (AC); Department of Pathology (GLA,CD), San Raffaele Scientific Institute, Milan, Italy Department of Biological and Technological Research, Cancer Immunotherapy and Gene Therapy Program, San Raffaele h Scientific Institute, Milan, Italy. 5Immunobiotechnology Unit, San Raffaele Institute, Milan, Italy; and Department of Oncology, Cancer Immunotherapy-Gene Therapy Program and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, Milan, Italy Department Biological and Technological Research (DIBIT)‐San Raffaele H Scientific Institutevia Olgettina 5820132MilanItaly Division of Molecular Oncology and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, via Olgettina 58, 20132 Milan, Italy |
Incoming Links
Total number of triples: 250.